Cryo Cell International (CCEL) Other Non-Current Liabilities (2016 - 2025)
Cryo Cell International (CCEL) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $47020.0 as the latest value for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities changed 0.0% to $47020.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $47020.0, a 0.0% change, with the full-year FY2025 number at $47020.0, changed 0.0% from a year prior.
- Other Non-Current Liabilities was $47020.0 for Q4 2025 at Cryo Cell International, down from $59.5 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $59.5 million in Q3 2025 to a low of $44226.0 in Q4 2023.
- A 5-year average of $22.0 million and a median of $1.3 million in 2021 define the central range for Other Non-Current Liabilities.
- Peak YoY movement for Other Non-Current Liabilities: crashed 99.91% in 2023, then soared 123818.26% in 2025.
- Cryo Cell International's Other Non-Current Liabilities stood at $35.4 million in 2021, then surged by 32.56% to $46.9 million in 2022, then plummeted by 99.91% to $44226.0 in 2023, then rose by 6.32% to $47020.0 in 2024, then changed by 0.0% to $47020.0 in 2025.
- Per Business Quant, the three most recent readings for CCEL's Other Non-Current Liabilities are $47020.0 (Q4 2025), $59.5 million (Q3 2025), and $58.2 million (Q2 2025).